A citation-based method for searching scientific literature

Hiroshi Kunugi, Hiroaki Hori, Shintaro Ogawa. Psychiatry Clin Neurosci 2015
Times Cited: 50







List of co-cited articles
548 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
24

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
24

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
20

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
D V Sheehan, Y Lecrubier, K H Sheehan, P Amorim, J Janavs, E Weiller, T Hergueta, R Baker, G C Dunbar. J Clin Psychiatry 1998
20

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
16

Stress, depression, and neuroplasticity: a convergence of mechanisms.
Christopher Pittenger, Ronald S Duman. Neuropsychopharmacology 2008
14

Are Japan's hikikomori and depression in young people spreading abroad?
Takahiro A Kato, Naotaka Shinfuku, Norman Sartorius, Shigenobu Kanba. Lancet 2011
47
14

A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
14

The corticosteroid receptor hypothesis of depression.
F Holsboer. Neuropsychopharmacology 2000
14

A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers.
Adrian L Lopresti, Garth L Maker, Sean D Hood, Peter D Drummond. Prog Neuropsychopharmacol Biol Psychiatry 2014
186
14

Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis.
Shintaro Ogawa, Takashi Fujii, Norie Koga, Hiroaki Hori, Toshiya Teraishi, Kotaro Hattori, Takamasa Noda, Teruhiko Higuchi, Nobutaka Motohashi, Hiroshi Kunugi. J Clin Psychiatry 2014
81
14

Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression.
F Lamers, N Vogelzangs, K R Merikangas, P de Jonge, A T F Beekman, B W J H Penninx. Mol Psychiatry 2013
373
14


Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
Elaine Setiawan, Alan A Wilson, Romina Mizrahi, Pablo M Rusjan, Laura Miler, Grazyna Rajkowska, Ivonne Suridjan, James L Kennedy, P Vivien Rekkas, Sylvain Houle,[...]. JAMA Psychiatry 2015
386
14

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia.
Akira Monji, Takahiro Kato, Shigenobu Kanba. Psychiatry Clin Neurosci 2009
289
12

Neurotransmitters, psychotropic drugs and microglia: clinical implications for psychiatry.
T A Kato, Y Yamauchi, H Horikawa, A Monji, Y Mizoguchi, Y Seki, K Hayakawa, H Utsumi, S Kanba. Curr Med Chem 2013
45
13


CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.
Vyara Valkanova, Klaus P Ebmeier, Charlotte L Allan. J Affect Disord 2013
451
12

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).
Ronald C Kessler, Patricia Berglund, Olga Demler, Robert Jin, Doreen Koretz, Kathleen R Merikangas, A John Rush, Ellen E Walters, Philip S Wang. JAMA 2003
12

Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments.
M Bilici, H Efe, M A Köroğlu, H A Uydu, M Bekaroğlu, O Değer. J Affect Disord 2001
486
12

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
819
12



Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview.
Tempei Otsubo, Katsutoshi Tanaka, Rumiko Koda, Junko Shinoda, Nana Sano, Satoshi Tanaka, Hiroshi Aoyama, Masaru Mimura, Kunitoshi Kamijima. Psychiatry Clin Neurosci 2005
348
12

Multidimensional anatomy of 'modern type depression' in Japan: A proposal for a different diagnostic approach to depression beyond the DSM-5.
Takahiro A Kato, Ryota Hashimoto, Kohei Hayakawa, Hiroaki Kubo, Motoki Watabe, Alan R Teo, Shigenobu Kanba. Psychiatry Clin Neurosci 2016
29
20

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?
Johann Steiner, Martin Walter, Tomasz Gos, Gilles J Guillemin, Hans-Gert Bernstein, Zoltán Sarnyai, Christian Mawrin, Ralf Brisch, Hendrik Bielau, Louise Meyer zu Schwabedissen,[...]. J Neuroinflammation 2011
321
12

Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.
Heath D Schmidt, Richard C Shelton, Ronald S Duman. Neuropsychopharmacology 2011
255
12

Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
12

Plasma Metabolites Predict Severity of Depression and Suicidal Ideation in Psychiatric Patients-A Multicenter Pilot Analysis.
Daiki Setoyama, Takahiro A Kato, Ryota Hashimoto, Hiroshi Kunugi, Kotaro Hattori, Kohei Hayakawa, Mina Sato-Kasai, Norihiro Shimokawa, Sachie Kaneko, Sumiko Yoshida,[...]. PLoS One 2016
52
12


The molecular neurobiology of depression.
Vaishnav Krishnan, Eric J Nestler. Nature 2008
10

Introducing the concept of modern depression in Japan; an international case vignette survey.
Takahiro A Kato, Naotaka Shinfuku, Daisuke Fujisawa, Masaru Tateno, Tetsuya Ishida, Tsuyoshi Akiyama, Norman Sartorius, Alan R Teo, Tae Young Choi, Anne P F Wand,[...]. J Affect Disord 2011
21
23

Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?
T A Kato, A Monji, Y Mizoguchi, S Hashioka, H Horikawa, Y Seki, M Kasai, H Utsumi, S Kanba. Mini Rev Med Chem 2011
77
10


Is depression associated with increased oxidative stress? A systematic review and meta-analysis.
Catherine N Black, Mariska Bot, Peter G Scheffer, Pim Cuijpers, Brenda W J H Penninx. Psychoneuroendocrinology 2015
274
10


The HPA axis in major depression: classical theories and new developments.
Carmine M Pariante, Stafford L Lightman. Trends Neurosci 2008
980
10

Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors.
Suchet D Khanzode, Ganesh N Dakhale, Shruti S Khanzode, Anand Saoji, R Palasodkar. Redox Rep 2003
290
10

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.
Michael Maes, Raz Yirmyia, Jens Noraberg, Stefan Brene, Joe Hibbeln, Giulia Perini, Marta Kubera, Petr Bob, Bernard Lerer, Mario Maj. Metab Brain Dis 2009
538
10

The biochemistry of affective disorders.
A Coppen. Br J Psychiatry 1967
605
10


Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects.
Yogesh Dwivedi, Hooriyah S Rizavi, Robert R Conley, Rosalinda C Roberts, Carol A Tamminga, Ghanshyam N Pandey. Arch Gen Psychiatry 2003
537
10

Inflammation and clinical response to treatment in depression: A meta-analysis.
R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
266
10

Is depression an inflammatory disorder?
Charles L Raison, Andrew H Miller. Curr Psychiatry Rep 2011
319
10

Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder.
Rita Haapakoski, Julia Mathieu, Klaus P Ebmeier, Harri Alenius, Mika Kivimäki. Brain Behav Immun 2015
423
10

Potential clinical utility of plasma amino acid profiling in the detection of major depressive disorder.
Hong-Bo Xu, Liang Fang, Zi-Cheng Hu, Yi-Chen Chen, Jian-Jun Chen, Fang-Fang Li, Jia Lu, Jun Mu, Peng Xie. Psychiatry Res 2012
30
16

Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy.
Knut A Hestad, Sverre Tønseth, Charlotte D Støen, Thor Ueland, Pål Aukrust. J ECT 2003
156
10

Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.
Daimei Sasayama, Kotaro Hattori, Chisato Wakabayashi, Toshiya Teraishi, Hiroaki Hori, Miho Ota, Sumiko Yoshida, Kunimasa Arima, Teruhiko Higuchi, Naoji Amano,[...]. J Psychiatr Res 2013
112
10

Biomarkers for depression: recent insights, current challenges and future prospects.
Rebecca Strawbridge, Allan H Young, Anthony J Cleare. Neuropsychiatr Dis Treat 2017
113
10

Psychotropic dose equivalence in Japan.
Toshiya Inada, Ataru Inagaki. Psychiatry Clin Neurosci 2015
199
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.